H2AX and cancer: These findings were further supported by the observation that the protein level of γ‐H2AX decreased in a dose‐dependent manner in HJC0152‐treated NSCLC cells, providing further evidence that HJC0152 induces DNA damage to suppress cancer cell proliferation and tumour growth and progression.